therefore the ability of the beta-receptor antagonist acebutolol ( 400 mg/die ) and of the diuretic mefrusid ( 25 mg/die ) to reduce exercise-induced increases in blood pressure and pressure-rate product during and after standardized ergometric work ( 50 -- 100 watts ) was compared in a within-patient study of 42 outpatients with arterial hypertension ( stage 1 to 2 , who ) aged 18 to 50 years .
C0000946
acebutolol
C0020538
arterial hypertension